MRM Health, a clinical-stage biopharmaceutical company developing microbiome-based therapeutics for inflammatory diseases and ...

Topadur Pharma, a clinical-stage biotechnology company specialising in therapies for vascular regeneration, has announced the ...

“The acquisition of Arthrosi allows us to expand our gout pipeline with a highly differentiated new asset. Pozdeutinurad has ...

BICO has announced the appointment of Jesper Hagberg as its new Chief Operations & Digital Officer.

Lindus Health and Quotient Sciences have announced a strategic partnership to enable enhanced patient recruitment and ...

Xmoor Pharma has established a strategic collaboration with the Translational Research Office (TRO) and University College ...

Title21 Health Solutions, a portfolio company specialising in supporting life science regulatory needs, has joined the Blood ...

Finnish biotechnology company NADMED has announced the launch of the NADMED Award 2026 in the hope of generating new discoveries in the field of metabolomics.

Beckley Psytech has announced positive topline results from its phase 2a study of ELE-101, a synthetic intravenous (IV) formulation of psilocin benzoate, for patients with Major Depressive Disorder ...

A British inquiry into the use of chemotherapy to treat seriously ill cancer patients has found the treatment caused or hastened death in 27% of cases. A British inquiry into the use of chemotherapy ...

SBT-77-7101 shows favourable safety and early signs of efficacy in patients with refractory RA Sonoma Biotherapeutics has announced positive interim results from its ongoing phase 1 Regulate-RA trial ...